Novartis' leukaemia drug Tasigna gets EU backing

ZURICH, Dec 23 (Reuters) - Swiss drugmaker Novartis AG
said on Thursday its blood cancer drug Tasigna had won
European backing to treat patients with a type of leukaemia,
giving its oncology...

Source: http://feeds.reuters.com/~r/reuters/hotStocksNews/~3/zuEij7Kmq3c/idUSZAT01100520101223

materials news environment merger news news new issue